DJIA 16,058.35 -469.68 -2.84%
NASDAQ 4,636.11 -140.40 -2.94%
S&P 500 1,913.85 -58.33 -2.96%
market minute promo

Incyte Corp (NASDAQ: INCY)

115.12 -1.07 (-0.92%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

INCY $115.12 -0.92%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $114.85
Previous Close $116.19
Daily Range $114.00 - $118.99
52-Week Range $43.86 - $121.93
Market Cap $20.8B
P/E Ratio 1,291.00
Dividend (Yield) $0.00 (0.0%)
Volume 1,717,513
Average Daily Volume 1,308,078
Current FY EPS -$0.17

Sector

Healthcare

Industry

Drug Makers

Incyte Corp (INCY) Description

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. Website: http://www.incyte.com/

News & Commentary Rss Feed

Are the 3 Best-Performing Big-Cap Biotech Stocks of 2015 Still Worth Buying?

BioMarin Pharmaceuticals, Incyte Corporation, and Regeneron Pharmaceuticals are soaring this year, and with valuation at lofty levels, investors will have to think long term if they're going to buy them.

SA Biotech Panel Discussion: Geron And Incyte, Imetelstat And Jakafi

3 Stocks Dragging The Drugs Industry Downward

Interesting INCY Put And Call Options For December 2016

Benzinga's Top Initiations

Pipeline Momentum Makes Biotech Stock Incyte Worth Watching

Why Incyte Corporation (INCY) Might Be a Diamond in the Rough

Incyte Q2 Loss Narrower-than-Expected, Ups Jakafi Outlook - Analyst Blog

Health Care Sector Update for 08/05/2015: ARIA, SCMP, INCY

Incyte (INCY) Earnings Report: Q2 2015 Conference Call Transcript

See More INCY News...

INCY's Top Competitors

INCY $115.12 (-0.92%)
Current stock: INCY
AMGN $147.46 (-2.85%)
Current stock: AMGN
GILD $101.49 (-3.41%)
Current stock: GILD
BIIB $292.50 (-1.61%)
Current stock: BIIB